← Eichor
Condition: Subcutaneous Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Subcutaneous

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

AnovaOS Network Powered Patient Registry
Phase N/A · 1 location(s) · Anova Enterprises, Inc · NCT05013944To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GB18 Injection in Health
Phase 1 · 1 location(s) · Shenzhen Kexing Pharmaceutical Co., Ltd. · NCT07237464LYmph Node eXamination in Cat Allergen Immunotherapy
EARLY_Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07447869A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection
Phase 2 · 39 location(s) · TG Therapeutics, Inc. · NCT07503873A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of a New Subcuta
Phase 1 · 12 location(s) · Hoffmann-La Roche · NCT07667322L19IL2/TNF in Patients With Basal Cell Carcinoma
Phase 2 · 18 location(s) · Philogen S.p.A. · NCT07227870To Compare the Pharmacokinetics and Safety of PBP1502 and Humira in Healthy Subjects
Phase 1 · 1 location(s) · Prestige Biopharma Limited · NCT05108259Effects of Erector Spinae Plane Block on Postoperative Pain Following Lumbar Fusion Surgery
NA · 1 location(s) · University of Massachusetts, Worcester · NCT06528288Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders
Phase 1/Phase 2 · 1 location(s) · University of Maryland, Baltimore · NCT07075510Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen
Phase 3 · 32 location(s) · Inmunotek S.L. · NCT04891237Nutritional Oleic Acid Modulation of adIpose Cholesterol Metabolism in Patients Living With Obesity
NA · 1 location(s) · Nantes University Hospital · NCT07027033InDuctIon TREatment with SubCuTaneous Infliximab for Crohn's Disease
Phase 3 · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT06059989Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thromb
Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05338190A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Phase 4 · 53 location(s) · Takeda · NCT06045754Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease
Phase N/A · 6 location(s) · Mercy Medical Center · NCT06750731Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine
Phase 1/Phase 2 · 6 location(s) · Mapi Pharma Ltd. · NCT07185815A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of INCA033989 Following Subcutaneous or Intravenous A
Phase 1 · 1 location(s) · Incyte Corporation · NCT07448155A Study of AIR-001 in Adults With Alpha-1 Antitrypsin Deficiency (AATD)
Phase 1 · 6 location(s) · AIRNA Corporation · NCT07431112Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"
Phase 3 · 9 location(s) · Kamada, Ltd. · NCT04204252A Phase 1 Clinical Study Comparing GS101 and Dupixent® After Subcutaneous Injection
Phase 1 · 1 location(s) · Jiangsu Genscend Biopharmaceutical Co., Ltd · NCT07411755A Study to Investigate the Safety, Pharmacodynamic and Pharmacokinetic Characteristics of CBP-4888 in Hospitalized Parti
Phase 1 · 3 location(s) · Comanche Biopharma · NCT07282171Investigation of the Audible ICD Alert Tone
Phase N/A · 1 location(s) · Universitätsklinikum Köln · NCT06388382A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (M
Phase 3 · 42 location(s) · Merck Sharp & Dohme LLC · NCT07513376A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rub
Phase 3 · 22 location(s) · GlaxoSmithKline · NCT06855160A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis
Phase 2/Phase 3 · 9 location(s) · UCB Biopharma SRL · NCT06055959Neoadjuvant Oral Paclitaxel Plus Subcutaneous Pertuzumab/Trastuzumab in Patients With HER2-positive Breast Cancer
NA · 9 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT07095023Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM)
Phase 1/Phase 2 · 2 location(s) · Starton Therapeutics, Inc · NCT06087653Safety and Efficacy of GL-2045 in Patients With Immune Thrombocytopenia
Phase 1 · 1 location(s) · Gliknik Inc. · NCT07605845A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-
Phase 2 · 1 location(s) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · NCT06505395Feasibility and Acceptability of Endoscopic Mastectomy in Patients With Breast Cancer
NA · 1 location(s) · University Hospital, Montpellier · NCT06569706
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.